An NCI-designated Comprehensive Cancer Center

Leukemia

“The doctors, the nurses and the environment give me nothing but hope.”
Alex Tung, leukemia survivor

Leukemia occurs most often in adults older than 55, but it is also the most common cancer in children younger than 15.

If you have been recently diagnosed with leukemia, talk to our world-renowned specialists at City of Hope. Our team is an integrated group of experts who will provide you the best possible care from the moment of diagnosis to active treatment to follow-up and survivorship.

Request a Consultation

If you have been diagnosed with leukemia or are looking for a second opinion consultation about your treatment, please contact us for more information.

Our Expertise

City of Hope, located in Southern California, has been named a best hospital for cancer by U.S. News & World Report for over a decade, and a National Cancer Institute comprehensive cancer center, the highest designation that recognizes our commitment to cancer treatment, research and education. As a founding member of the National Comprehensive Cancer Network, our doctors also help develop and improve evidence-based leukemia treatment guidelines for patients throughout the country.

Highlights of our leukemia program include:

  • A multidisciplinary team of specialists – including hematologists, medical and radiation oncologists, scientists, supportive care experts and other professionals – who work together to provide coordinated, personalized care for you and your loved ones
  • The Gehr Family Center for Leukemia is home to a team of basic scientists whose laboratory research focuses on both furthering our understanding of the causes of leukemia (leukemogenesis) and developing new disease-specific therapeutics
  • Comprehensive molecular profiling and risk assessment tests that can help identify treatments that will produce the best outcomes
  • A world-class bone marrow and stem cell transplant program with better than expected survival outcomes for over 10 years
  • Leading-edge clinical trials for leukemia not available elsewhere, including CAR T cell immunotherapy, mutation-specific drugs and novel stem cell transplant regimens
  • Total marrow irradiation that targets radiation therapy to bone marrow while minimizing exposure to healthy tissues and organs
  • Specialized observation programs for slow-growing leukemia subtypes, allowing our doctors to deliver timely therapies when they are the most effective
  • Long-term, follow-up program to minimize risk of recurrence and improve quality of life for leukemia survivors

 

News & Breakthroughs

GIVE HOPE

Help us turn innovative ideas into powerful new treatments
$110
$260
$500
$1000
$ Other
Donate